Entity Address, City or Town Proceeds from Related Party Debt Borrowings under related party notes payable Entity Ex Transition Period Earnout Rights Stock Price Trigger Earnout Rights Stock Price Trigger Earnout Rights Stock Price Trigger Fair Value Disclosures [Abstract] Earnings Per Share [Abstract] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Schedule of Accrued Liabilities [Table Text Block] Condensed Consolidated Balance Sheets of Accrued expense 2026 Finance Lease, Liability, to be Paid, Year Three Stock Issued During Period, Value, New Issues Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Common stock held in trust account Common Stock Held in Trust Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount Redeemable noncontrolling interest (Increase)/Decrease In ProKidney Corp. Accumulated Deficit For Impact Of Subsidiary Equity-Based Compensation Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Subsidiary Equity-Based Compensation Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Subsidiary Equity-Based Compensation Notes payable, related parties Notes Payable, Related Parties Amendment Flag Subsequent Event Type [Domain] Subsequent Event Type [Domain] Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amortization Payments of Ordinary Dividends, Total Payments of Ordinary Dividends ProKidney Corp. ordinary shares Redeemable Noncontrolling Interest. Redeemable Noncontrolling Interest[Member] Operating Lease, Right-of-Use Asset Right of use assets, net Right of use assets Schedule Of Intangible Asset Schedule of Finite-Lived Intangible Assets [Table Text Block] Underwriting fee Underwriting Fee Underwriting fee. Document Quarterly Report Share based compensation arrangement by share based payment award fair value assumptionsestimated equity value. Share Based Compensation Arrangement By Share Based Payment Award Fair Value AssumptionsEstimated Equity Value Total equity value Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Less: imputed interest Net Loss Per Ordinary Share Earnings Per Share, Policy [Policy Text Block] Cash and Cash Equivalents [Domain] Statement [Table] Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Operating lease liabilities, noncurrent Chief Executive Officer [Member] 2024 Finance Lease, Liability, to be Paid, Year One Capital contribution Proceeds from Contributed Capital Equity Option [Member] Stock Option [Member] Weighted Average Exercise Price, Forfeited | $ / shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Cash paid for operating leases Operating Lease, Payments Right of use assets operating and finance lease Right Of Use Assets Operating And Finance Lease Right of use assets, net Right Of Use Assets Operating And Finance Lease Business Acquisition [Axis] Fair Value Option, Disclosures [Table] Profits Interests granted Profits Interests granted Profits interests granted Common Stock, Capital Shares Reserved for Future Issuance Ordinary shares reserved for issuance Weighted Average Grant Date Fair Value,awards outstanding at March 31, 2023 Weighted Average Grant Date Fair Value, Unvested awards outstanding at January 1, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Description Of Organization, Business Operations And Going Concern Nature of Operations [Text Block] Vesting of Class B restricted stock rights During Period Shares Vesting of Class B restricted stock rights During Period Shares Vesting of Class B restricted stock rights, Shares Proceeds from business combination gross Proceeds from business combination gross Proceeds from business combination gross Earnout Restricted Common Units Earnout Restricted Common Units Earnout Restricted Common Units Issued Share-Based Award Threshold Trading Days Share-Based Award Threshold Trading Days Construction in Progress, Gross Construction in progress Less: Net loss attributable to noncontrolling interest Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable Lessee, Operating Leases [Text Block] Leases Schedule of Maturities of Lease Liabilities Nefro consulting service Nefro consulting service Advisory and placement fees Advisory and placement fees Share-Based Payment Arrangement, Option [Member] Stock option awards granted [Member] Related Party Transaction, Rate Interest rate on notes Director Restricted Stock Unit Award Agreement [Member] Director restricted stock unit award agreement . Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Total liabilities and shareholders' deficit/members' equity Liabilities and Equity Deferred underwriting fee Deferred Underwriting Fees Deferred underwriting fee. Accumulated Other Comprehensive Income AOCI Including Portion Attributable to Noncontrolling Interest [Member] Plan Name [Domain] Forfeited/ shares Forfeited | shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Operating and finance lease weighted average discount rate percent Operating And Finance Lease Weighted Average Discount Rate Percent Operating And Finance Lease Weighted Average Discount Rate, Percent Vested, Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Class B Ordinary Shares [Member] Class B Ordinary Shares [Member] Class B Ordinary Shares Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator Unrealized gain (loss) on marketable securities Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Entity Incorporation, State or Country Code Income Statement [Abstract] Weighted Average Exercise Price Time-vested options exercisable at March 31, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-Based Payment Arrangement, Tranche Three [Member] Tranche three [Member] Investments [Abstract] weighted average remaining lease term Finance Lease, Weighted Average Remaining Lease Term Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net, Total Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net Change from net loss available to Class A ordinary shareholders and change in ownership interest in ProKidney LP Finance lease liabilities, current Sale of Stock [Domain] Sale of Stock [Domain] Total current liabilities Liabilities, Current Accrued manufacturing improvement costs, current portion. Accrued Manufacturing Improvement Costs Current Manufacturing improvement costs Capital Units by Class [Axis] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Change in redemption value of noncontrolling interest Change in redemption value of noncontrolling interest Noncontrolling Interest, Change in Redemption Value Less: Total comprehensive loss attributable to noncontrolling interest Less: Total comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total Business Acquisition, Acquiree [Domain] Fair Value Measurements Recurring Member Fair Value, Recurring [Member] Interest Expense, Total Interest Expense Interest expense Share-Based Payment Arrangement, Tranche Two [Member] Tranche two [Member] Accrued clinical study related costs, current portion. Accrued Clinical Study Related Costs Current Clinical study related costs Income Taxes Income Tax, Policy [Policy Text Block] Operating and finance lease liability Operating And Finance Lease Liability Present value of lease liabilities Net loss Available To Class A ordinary Shareholders of ProKidney Corp., Diluted Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted Preferred stock shares authorized Preferred Stock, Shares Authorized Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share based compensation arrangement by share based payment award fair value assumptions discount for lack of marketability. Share Based Compensation Arrangement By Share based Payment Award Fair Value Assumptions Discount For Lack Of Marketability Discount for lack of market Operating lease, weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Entity Small Business Number of Reportable Segments Number of Reportable Segments Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total Cash, beginning of period Cash, end of period Cash, end of period Net cash contribution Net cash contribution Net cash contribution Investments [Domain] Time Vested Awards [Member] Time Vested Awards [Member] Total Current Assets Assets, Current Property, Plant and Equipment [Line Items] Facility Expansion Costs FacilityExpansionCosts FacilityExpansionCosts Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block] Summary of Profits Interest awards, Activity Weighted Average Exercise Price Time-vested options vested and expected to vest at March 31, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Costs Of Business Combination Costs Of Business Combination Costs Of Business Combination Share based compensation shares forfeited during the period Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Tax Receivable Agreement [Member] Tax Receivable Agreement [Member] Tax Receivable Agreement [Member] Weighted Average Number of Shares Outstanding, Basic Weighted Average Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Finance Lease, Liability Total finance lease liabilities Present value of lease liabilities City Area Code ProKidne KY and Nefro Health Member ProKidney KY and Nefro Health [Member] ProKidney KY and Nefro Health [Member] Aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Weighted Average Period Weighted Average Period Share-Based Payment Arrangement [Abstract] Liabilities Total liabilities Private Placement [Member] Document Period End Date Repayments of related party debt Repayments of Related Party Debt Repayment of related party notes payable Restricted Stock [Member] Restricted Stock Rights Construction in Progress [Member] Construction in progress Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value and Profits Interests granted Weighted average grant date fair value of options granted Percentage Of Non Voting Economic Interest By Parent Percentage Of Non Voting Economic Interest By Parent Percentage Of Non Voting Economic Interest by Parent Vesting period Vesting period Share-Based Payment Arrangement, Tranche One [Member] Tranche one [Member] Finite-Lived Intangible Asset, Expected Amortization, Year One Finite lived intangible asset one year Statistical Measurement [Axis] Expected dividend yield Expected dividend yield Other Assets, Current Other current assets Subsequent Event [Line Items] Percentage Of Non Voting Economic Interest Percentage Of Non Voting Economic Interest Percentage Of Non Voting Economic Interest Related Party [Axis] 2027 Lessee operating lease and finance lease liability payments due year five. Lessee Operating Lease And Finance Lease Liability Payments Due Year Five Assets Total assets Interest Expense, Related Party Interest expense Earnout Restricted Stock Right shares Earnout restricted stock right shares Quarterly Related Party Fee Quarterly Related Party Fee Administration And Support Services [Member] Net loss per share attributable to Class A ordinary shares, Diluted Diluted net loss per ordinary share Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Entity Address, Postal Zip Code Net loss after the Business Combination Net loss after the Business Combination Net loss after the Business Combination Document Fiscal Period Focus Operating leases Operating leases: Deferred offering costs Deferred Offering Costs Conversion of Stock, Shares Converted Conversion of converted shares APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Equity-based payments Number of shares of common stock committed to settle on a date following the year Business combination occurs Number of Shares Of Common Stock Committed To Settle On A Date Following The Year Business Combination Occurs Number of shares of common stock committed to settle on a date following the year Business combination occurs. Operating Lease, Liability Total operating lease liabilities Lease Liability Present value of lease liabilities Net Cash Provided by (Used in) Financing Activities Net cash flows provided by financing activities Selling general and administrative expenses from transactions with related party Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party 2026 Lessee operating lease and finance lease liability payments due year four. Lessee Operating Lease And Finance Lease Liability Payments Due Year Four Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period Stock option award granted, shares Statement of Financial Position [Abstract] Total Share Authorized Total Share Authorized Total Shares Authorized Entity File Number Lessee operating lease and finance lease liability payments due after year five. Lessee Operating Lease And Finance Lease Liability Payments Due After Year Five Thereafter Finance Lease, Liability, to be Paid Total lease payments Statement of Cash Flows [Abstract] Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Business Combination, Consideration Transferred, Liabilities Incurred Business combination, consideration transferred incurred Sponsor [Member] Prepaid clinical current Prepaid Clinical Current Prepaid clinical Statistical Measurement [Domain] Statement of Stockholders' Equity [Abstract] Finance leases: Finance leases: Sale of Stock [Axis] Sale of Stock [Axis] Share-Based Payment Arrangement, Plan Modification, Incremental Cost Additional compensation expense (Increase)/Decrease In ProKidney Corp. Additional Paid-in Capital For Vesting Of Restricted Common Units in ProKidney LP Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Restricted Common Units Vesting Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Restricted Common Units Vesting Class of Stock [Domain] Class of Stock [Domain] Conversion of Stock, Shares Issued Conversion of shares Stockholders' Equity Note [Abstract] Subsequent Events [Abstract] PKLP Member PKLP [Member] PKLP [Member] Schedule of Fixed Assets Property, Plant and Equipment [Table Text Block] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Finite Lived Intangible Asset Reminder Of Fical Year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Business Acquisition Cost Of Acquired Entity Transaction Costs Business Acquisition, Transaction Costs Subsequent Events Subsequent Events [Text Block] Vesting percent Vesting percent Weighted Average Number Of Shares Outstanding, Diluted Weighted Average Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Due to related parties Due to Related Parties Due to Related Parties, Total Accrued compensation and related costs current. Accrued Compensation And Related Costs Current Compensation Finite-Lived Intangible Assets, Major Class Name [Domain] Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Corporate debt securities Member Corporate Debt Securities [Member] Computer Equipment [Member] Computer equipment and software General and Administrative Expense [Member] General and administrative Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Commercial paper Member Commercial Paper [Member] Description Of Terms Earnout Shares Description Of Terms Earnout Shares Current Fiscal Year End Date Investment Type [Axis] Profits Interest awards [Member] Profits Interest awards [Member] Profits Interest awards [Member] Depreciation, Total Depreciation Depreciation expense Financial Instruments [Domain] Entity Address, Address Line One Noncontrolling Interest [Member] Noncontrolling Interest [Member] Investments Cash, Cash Equivalents, and Marketable Securities [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Previously Recognized Expense Settled Via Equity Award for the services. Previously Recognized Expense Settled Via Equity Award Related Party Note Maximum Amount Related Party Note Maximum Amount Related Party Note Maximum Amount Contingent Consideration Type [Domain] Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Income tax expense Income tax (benefit) expense Fair Value, Option, Quantitative Disclosures [Line Items] Proceeds from unredeemed shares Proceeds from unredeemed shares Proceeds from unredeemed shares Income Tax Disclosure [Text Block] Income Taxes Vesting [Axis] Preferred Stock, Shares Issued Preferred stock ,shares issued Other Accrued Liabilities, Current Other accrued expenses Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchase of equipment and facility expansion Purchase of equipment and facility expansion Agreement [Axis] Agreement . Income Tax Disclosure [Abstract] Pre IPO Sponsor Promissory Note [Member] Pre IPO Sponsor Promissory Note [Member] Pre IPO sponsor promissory note Share Based Payment Award Market Based Vesting Condition Per Share Share Based Payment Award Market Based Vesting Condition Per Share Emerging Growth Company Emerging Growth Company Status [Policy Text Block] Emerging growth company status [policy text block]. Stock issued during period, shares, new issues Stock issued during period new shares issued Stock Issued During Period, Shares, New Issues Summary of assumptions of the valuation scenarios [Line Items] Summary of assumptions of the valuation scenarios [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Marketable securities held in Trust Account Marketable Securities Held To Maturity Fair Value Disclosure Marketable securities held to maturity fair value disclosure. Fair Value Hierarchy and NAV [Axis] Share-Based Payment Arrangements Share-based Payment Arrangement [Policy Text Block] Equity-Based Compensation Rights [Member] Earnout Rights [Member] Equity [Abstract] 2027 Finance Lease, Liability, to be Paid, Year Four Operating loss Operating Income (Loss) Operating loss Accrued Expenses Accrued Expenses [Policy Text Block] Accrued expenses. Related Party [Domain] Finance Lease, Liability, to be Paid, after Year Five Thereafter Offering Costs Deferred Offering Costs [Policy Text Block] Deferred offering costs [policy text block]. Waiting period after which the share trading days are considered Waiting Period After Which The Share Trading Days Are Considered Waiting period after which the share trading days are considered. Accrued Professional Fees, Current Accrued consulting and professional fees Common Stock, Voting Rights Common stock, voting rights Entity Filer Category Payments to Acquire Marketable Securities, Total Purchases Of Marketable Securities Payments to Acquire Marketable Securities Sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Total comprehensive loss attributable to Class A ordinary shareholders Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Shares Unlocked Percentage Shares Unlocked Percentage Operating and formation costs Operating Expenses Total operating expenses Entity Current Reporting Status Asset Class [Domain] Net loss attributable to noncontrolling interest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest, Total Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Net loss and comprehensive loss attributable to noncontrolling interest Aggregate intrinsic value exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Finite-Lived Intangible Assets, Net, Total Finite-Lived Intangible Assets, Net, Beginning Balance Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net Fixed assets, net Intangible assets, net Beginning Balance Ending Balance Stockholders' Equity Attributable to Parent Total members' equity Total equity value Total shareholders' deficit / members equity Number of trading days for determining the share price Number Of Trading Days For Determining The Share Price Number of trading days for determining the share price. Independent Directors [Member] Asset Class [Axis] Entity Tax Identification Number Income Statement Location [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of Shares, Forfeited Number of Shares, Forfeited Common stock value Common Stock, Value, Issued Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Equipment [Member] Furniture and equipment Equity Components [Axis] Class A Ordinary Shares Subject to Possible Redemption Temporary Equity [Policy Text Block] Temporary equity [Policy text block]. Consolidated Entities [Domain] Founder [Member] Shares no longer subject to forfeiture Shares No Longer Subject To Forfeiture Shares no longer subject to forfeiture. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Leases [Abstract] Earnout restricted common units. Earnout Restricted Common Units [Member] RCU [Member] Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Accounts payable and accrued expenses Entity Emerging Growth Company Mineral Rights Earnout Rights Related Party Transaction [Axis] Operating Expenses [Abstract] Operating expenses Due in 1 year through 5 years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Schedule of Stock by Class [Table] (Gain)/Loss On Marketable Securities, Net (Gain)/loss on marketable securities, net Marketable Securities, Gain (Loss) Government bond [Member] Government Bond [Member] Government Bond Member Earnout restricted stock rights. Earnout Restricted Stock Rights [Member] RSR [Member] Expected volatility, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Document Transition Report Sale of stock, number of shares issued in transaction Sale of Stock, Number of Shares Issued in Transaction Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Depreciation, Depletion and Amortization, Total Depreciation, Depletion and Amortization Depreciation and amortization Twenty Thousand Twenty Two Equity Incentive Plan [Member] Twenty Thousand Twenty Two Equity Incentive Plan [Member] 2022 Equity Incentive Plan [Member] Lessee Operating And Finance Lease Liability Maturity Table Text Block Lessee Operating And Finance Lease Liability Maturity Table Text Block Schedule of maturities of lease liabilities Sale of stock price per share Sale of Stock, Price Per Share Accumulated other comprehensive income Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Entity Common Stock, Shares Outstanding Other comprehensive loss Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Net loss available to Class A ordinary shareholders Net loss including noncontrolling interest Net Loss Net Income (Loss) Attributable to Parent Operating Lease, Liability, Current Lease liabilities, net of current portion Operating lease liabilities, current Contingent Liabilities Contingent Liability Reserve Estimate, Policy [Policy Text Block] Contingent Liabilities Proceeds from business combination Proceeds from business combination Additional Paid-in Capital [Member] Impact of equity transactions on redeemable noncontrolling interest Noncontrolling Interest, Increase from Subsidiary Equity Issuance Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Summary of Profits Interest awards, Activity Document Information [Line Items] Subsidiaries [Member] Subsidiaries [Member] Entity Registrant Name Expected life of options, in years Expected life of options, in years Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value Private Placement [Abstract] Earnings Per Share [Text Block] Net Loss per Share Summary of assumptions of the valuation in stock option activity Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Related party transaction fees payable per month Related Party Transaction, Amounts of Transaction Class of Stock [Axis] Class of Stock [Axis] Share-Based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Equity-based compensation Restricted Stock Unit Awards Vesting During Period Restricted Stock Unit Awards Vesting During Period Business combination, Class A ordinary shares Statement of Comprehensive Income [Abstract] Property, Plant and Equipment, Net Total fixed assets, net Fixed assets, net Weighted average remaining contractual life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Award Type [Domain] Statement [Line Items] Operating Lease, Expense Operating Lease Expense Title of 12(b) Security Finite-Lived Intangible Assets, Gross, Total Finite-Lived Intangible Assets, Gross Gross carrying amount Equity Interest Issued or Issuable, Type [Domain] Ownership [Domain] Common Stock [Member] Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Marketable Securities Held in Trust Account Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Stock Option Awards Under Twenty Twenty Two Plan [Member] Stock Option Awards Under Twenty Twenty Two Plan [Member] Stock Option Awards Under Twenty Twenty Two Plan Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Weighted Average Vesting Price Weighted Average Vesting Price Equity Component [Domain] Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements 2023 Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income taxes Finance Lease, Liability, Undiscounted Excess Amount Less: imputed interest Less: imputed interest Entity Address, State or Province 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Due in 1 year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net change in cash and cash equivalents Total comprehensive loss including noncontrolling interest Total comprehensive loss including noncontrolling interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Document Type Noncontrolling Interest Disclosure [Text Block] Redeemable Noncontrolling Interest Entity Shell Company Operating and finance lease liabilities non current portion Operating And Finance Lease Liabilities Non Current Portion Lease liabilities, net of current portion Lessee operating and finance lease table text block Lessee Operating And Finance Lease Table Text Block Schedule of the classification of operating and finance lease assets and obligations in the Company's Consolidated Balance Sheets Share-Based Payment Arrangement, Expense Total equity-based compensation expense Research and Development in Process Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Transaction costs incurred inconnection with initial public offering Transaction Costs Incurred In Connection With Initial Public Offering Transaction costs incurred in connection with initial public offering. Loss Contingencies [Line Items] Security Exchange Name Class of Stock [Line Items] Finance lease liabilities, noncurrent Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net Cash Provided by (Used in) Operating Activities Net cash flows used in operating activities Equity Interest Type [Axis] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Grant period Unrecognized compensation expense remaining period Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Commitments and Contingencies Disclosure [Abstract] Increase (Decrease) in Income Taxes Payable Income taxes payable Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Current Restricted Stock Units (RSUs) [Member] RSU [Member] Principles of Consolidation Consolidation, Policy [Policy Text Block] 2025 Finance Lease, Liability, to be Paid, Year Two Employee Stock Ownership Plan (ESOP), Shares in ESOP, Total Employee Stock Ownership Plan (ESOP), Shares in ESOP Stock options granted under the 2022 Equity Incentive Plan Earnout rights stock price. Earnout Rights Stock Price Share price Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Common stock shares outstanding Common stock shares outstanding Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Over-Allotment Option [Member] Fair Value Inputs Level2 Member Fair Value, Inputs, Level 2 [Member] PWERM [Member] PWERM [Member] PWERM [Member] Total Total Debt Securities, Available-for-Sale Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows used in investing activities Commitments And Contingencies Commitments and Contingencies Common Stock, Shares, Issued Ordinary shares Common stock, shares issued Cash Saving Percentage CashSavingPercentage CashSavingPercentage Change in redemption value of noncontrolling interest Change in redemption value of noncontrolling interest Change in redemption value of noncontrolling interest Minimum [Member] Minimum [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Description Profits Interest vesting description Schedule of Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalents and Investments [Table Text Block] Limited Partnership Agreement [Member] Limited Partnership Agreement [Member] Limited Partnership Agreement Marketable securities Marketable Securities Marketable Securities, Total Investment Maturity Date Investment Maturity Date Stock shares issued during the period for services value Issuance of Class B ordinary shares to Sponsor Stock Issued During Period, Value, Issued for Services Risk-free interest rate, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Difference between tax rates Lessee, Leases [Policy Text Block] Leases Common Class B [Member] Common Class B [Member] PKLP Class B Units outstanding [Member] Accrued Liabilities, Current Accrued expenses and other Total accrued expenses and other Shareholder's Equity Stockholders' Equity Attributable to Parent [Abstract] Fair value of shares granted Share based Compensation Arrangement By Share based Payment Award Options Granted In Period Fair Value Share based Compensation Arrangement By Share based Payment Award Options Granted In Period Fair Value. Accrued Income Taxes, Noncurrent Income tax payable, net of current portion Entity Address, Address Line Two Workforce Intangible Asset Other Intangible Assets [Member] Founder Shares [Member] Capital Unit, Class B [Member] Unit Class B [Member] Cash and Cash Equivalents [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Forfeited Amortization of Intangible Assets Amortization expense Award Type [Axis] Subsequent Event [Member] Subsequent Event [Member] Related Party Transaction [Domain] Loss Contingencies [Table] Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets 2023 Lessee Operating Lease And Finance Lease Liability Payments Due Remainder Of Fiscal Year Lessee operating lease and finance lease liability payments due remainder of fiscal year. Share Based Payment Award Market Based Vesting Condition Share Based Payment Award Market Based Vesting Condition Weighted average price, description Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Non controlling interest percentge Proceeds from private placement issue Proceeds from Issuance of Private Placement Research and Development Expense, Total Research and Development Expense Recognized additional research and development expense Research and development Lessee, Operating Lease, Liability, to be Paid Total lease payments Investment Income, Nonoperating, Total Investment Income, Nonoperating Interest income Entity Central Index Key Percentage of tax saving recognized Percentage of tax saving recognized Accounting Policies [Abstract] Market-Vested Awards [Member] Market-Vested Awards [Member] weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total Finance Lease, Right-of-Use Asset, after Accumulated Amortization Right of use assets Interest Receivable Interest Receivable Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Less: accumulated depreciation Property, Plant and Equipment [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility of total equity Share Price Range [Domain] Finance lease, weighted average discount rate Finance Lease, Weighted Average Discount Rate, Percent ProKidney LP [Member] ProKidney LP [Member] Measurement Frequency [Axis] Equipment and facility expansion included in accounts payable and accrued expenses Equipment and facility expansion included in accounts payable and accrued expenses Equipment and facility expansion included in accounts payable and accrued expenses 2024 Lessee operating lease and finance lease liability payments due year two. Lessee Operating Lease And Finance Lease Liability Payments Due Year Two Share-Based Payment Arrangement [Text Block] Equity Based Compensation Antidilutive securities Antidilutive securities Numerator. Numerator [Abstract] Numerator Subsequent Event [Table] General and Administrative Expense, Total General and Administrative Expense General and administrative Organization, Consolidation and Presentation of Financial Statements [Abstract] Document Information [Table] Limited Partners' Capital Account, Units Outstanding Weighted Average Exercise Price, Time-vested Options Outstanding, Ending Balance | $ / shares Weighted Average Exercise Price, Time-vested Options Outstanding, Beginnig Balance | $ / shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Finance Lease, Principal Payments Payments on finance leases Payments on finance leases Share-Based Compensation Arrangement By Share-Based Payment Award Plan Modification Incremental Compensation Cost Recognized Upon Modification Share-Based Compensation Arrangement By Share-Based Payment Award Plan Modification Incremental Compensation Cost Recognized Upon Modification Recognized compensation expense modification Research and Development Expense [Member] Research and development Risk-free interest rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Working capital loans convertible into equity warrants Working Capital Loans Convertible Into Equity Warrants Working capital loans convertible into equity warrants. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right of use assets obtained in exchange for lease obligations Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss before noncontrolling interest to net cash flows used in operating activities: Accumulated Deficit [Member] Retained Earnings [Member] Accounting Policies [Line Items] Lessee operating lease and finance lease liability undiscounted excess amount. Lessee Operating Lease And Finance Lease Liability Undiscounted Excess Amount Less: imputed interest Schedule Of Estimated Useful Lives Estimated Useful Lives Assets Table Text Block Estimated Useful Lives Assets Table Text Block. Money market funds Member Money Market Funds [Member] Effective Income Tax Rate Reconciliation, Percent, Total Effective Income Tax Rate Reconciliation, Percent Effective tax rate Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Fair Value Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value Loss on disposal of equipment Gain (Loss) on Disposition of Property Plant Equipment, Total Gain (Loss) on Disposition of Property Plant Equipment Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross Fixed Assets Gross Restricted Stock Rights [Member] Restricted stock rights[Member]. Additional paid-in capital Additional Paid in Capital Additional Paid in Capital, Total Costs and Expenses, Related Party Costs And Expenses Related Party Entity Interactive Data Current Description of earnout rights. Description of earnout rights Related Party Transactions Related Party Transactions Disclosure [Text Block] Share-Based Payment Arrangement, Activity [Table Text Block] Summary of stock option awards granted, Activity Related Party Transactions [Abstract] 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Leasehold Improvements [Member] Leasehold improvements Net loss Available To Class A ordinary Shareholders of ProKidney Corp., Basic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic Gross proceeds Proceeds from Issuance Initial Public Offering Local Phone Number Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Unrecognized Tax Benefits Unrecognized tax benefits Summary of Assets that are Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] R&D service provider [Member] R&D service provider [Member] Accrued legal expense current. Accrued Legal Expense Current Accrued legal costs Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net loss per share Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Accounting Policies [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Time-vested options exercisable at March 31, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number IPO [Member] IPO [Member] Consolidated Entities [Axis] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Number of shares, Granted Unrecognized Tax Benefits, Period Increase (Decrease), Total Unrecognized Tax Benefits, Period Increase (Decrease) Uncertain tax positions Vesting [Member] Vesting [Member] Vesting [Member] ProKidne US and Nefro Health Member ProKidne US and Nefro Health Member ProKidney US and Nefro Health [Member] Income Statement Location [Domain] Share-Based Award Threshold Consecutive Trading Days Share-Based Award Threshold Consecutive Trading Days Number of Shares, awards outstanding at March 31, 2023 Number of Shares, Unvested awards outstanding at January 1, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number ProKidney Corp. Ordinary Shares Beginning Balance (in shares) Ending Balance (in shares) Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets Prepaid and other assets Prepaid and other assets Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share based compensation arrangement by share based payment award fair value assumptions expected time to exit event. Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Time To Exit Event Expected time to exit event Contingent Consideration by Type [Axis] Share Price Range [Axis] Incorporation date of entity Entity Incorporation, Date of Incorporation Stock options granted under the 2022 Equity Incentive Plan Time-vested options outstanding at March 31,2023 Time-vested options outstanding at January 1, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share price Share Price Common Class A [Member] Common Class A [Member] Class A [Member] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block] Summary of Company and transfers to noncontrolling interest: Document Fiscal Year Focus Operating and finance lease liabilities current Operating And Finance Lease Liabilities Current Lease liabilities Operating And Finance Lease Liabilities Current Working Capital Working capital . 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Interest Receivable Increase (Decrease) in Accrued Interest Receivable, Net Vesting [Domain] Net loss per share attributable to Class A ordinary shares, Basic Basic net loss per ordinary share Earnings Per Share, Basic Earnings Per Share, Basic, Total Other Prepaid Expense, Current Prepaid assets ASSETS Assets [Abstract] Expected volatility, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price Weighted average price Number of consecutive trading days for determining the share price Number Of Consecutive Trading Days For Determining The Share Price Number of consecutive trading days for determining the share price. Debt instrument face value Debt Instrument, Face Amount Financial Instrument [Axis] Weighted average remaining contractual life Weighted average remaining contractual life Schedule of share based payment award profits interest valuation assumptions table text block. Schedule Of Share Based Payment Award Profits Interest Valuation Assumptions Table Text Block Summary of assumptions of the valuation scenarios Earnout Right Vesting Period Earnout Right Vesting Period Vesting Period of Earnout Rights Long-Lived Tangible Asset [Axis] Lock Up Agreement Member Lock Up Agreement [Member] Lock Up Agreement [Member] Shareholders' Equity and Share-Based Payments [Text Block] Shareholders' Equity Liabilities and Equity [Abstract] Liabilities and Equity PIPE Investors [Member] Property, Plant and Equipment, Policy [Policy Text Block] Fixed Assets Net loss Net loss before noncontrolling interest Net loss including noncontrolling interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss available to Class A ordinary shareholders Current assets Assets, Current [Abstract] Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite lived intangible asset Two year Noncontrolling Interest [Abstract] Common stock, shares, subject to forfeiture Common Stock, Other Shares, Outstanding Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Earnout shares Earnout Shares Earnout shares. Fair Value Hierarchy and NAV [Domain] Advances from related party current Advances Payable To Related Party Current Advances payable to related party current. Measurement Frequency [Domain] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Intangible Assets Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Share-Based Payment Arrangement, Expense, after Tax Share-based compensation expense Outstanding amount remain in trust account immediately prior to the closing of public shares redemption Amount Held in trust Account Amount held in trust account . Description Of Organization And Business Operations [Table] Related Party Transaction [Line Items] Proceeds from business combination net Proceeds from business combination net Proceeds from business combination net Cover [Abstract] Equity-based compensation Employee Benefits and Share-Based Compensation Agreement [Domain] Agreement . 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Number of Shares, Vested Number of Shares, Vested Advance From Related Party Loan [Member] Current liabilities Liabilities, Current [Abstract] Maximum [Member] Maximum [Member] Unrealized gain on marketable securities Marketable Securities, Unrealized Gain (Loss) Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Compensation expense related to share-based awards Net Cash Provided by (Used in) Investing Activities Net cash flows used in investing activities 2025 Lessee operating lease and finance lease liability payments due year three. Lessee Operating Lease And Finance Lease Liability Payments Due Year Three Summary of Scheduled Maturity for Marketable Securities Investments Classified by Contractual Maturity Date [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Promissory Note [Member] Stock Issued During Period, Shares, Restricted Stock Award, Gross Legacy SCS Restricted Share Units Cash held contribution for SCS account Cash held contribution for SCS account Capital Unit, Class A [Member] Unit Class A [Member] Lessee operating lease and finance lease liability payments due Lessee Operating Lease And Finance Lease Liability Payments Due Total lease payments Cash Cash Stock shares issued during the period for services shares Issuance of Class B ordinary shares to Sponsor (in shares) Stock Issued During Period, Shares, Issued for Services Segment Reporting, Policy [Policy Text Block] Segments Time-vested options vested and expected to vest at March 31, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Property, Plant and Equipment, Useful Life Estimated useful lives OPM [Member] OPM [Member] OPM [Member] Finite-Lived Intangible Asset, Expected Amortization, Year Three Finite lived intangible asset Three year Common Stock, Shares Authorized Authorized capital stock Common stock, shares authorized Trading Symbol ProKidney Corp. ProKidney Corp [Member] Ownership [Axis] Time Deposit [Member] Time Deposit Member Title of Individual [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Limited Partners' Capital Account, Units Issued Class A Ordinary Shares [Member] Class A Ordinary Shares [Member] Class A Ordinary Shares Exchange Agreement [Member] Exchange Agreement Exchange Agreement [Member] Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Unrealized Losses Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Plan Name [Axis] Schedule of Related Party Transactions, by Related Party [Table] Title of Individual [Axis] Director [Member] Long-Lived Tangible Asset [Domain] Capital Unit, Class [Domain] Common Stock, Par or Stated Value Per Share Common stock, par value Stock issued during period new issues Stock Issued During Period, Shares, Acquisitions Issuance of Class B ordinary shares to Sponsor (in shares) Costs Paid With Proceeds For SPAC Costs Paid With Proceeds For SPAC Costs paid with proceeds for SPAC Profits Interests Issued To Service Provider, par value Profits Interests Issued To Service Provider Change in redeemable noncontrolling interest for equity compensation and equity transactions. Change In Redeemable Noncontrolling Interest For Equity Compensation And Equity Transactions Impact of equity transactions and compensation on redeemable noncontrolling interest Aggregate amount paid to holders for exercised right to have public shares redeemed from trust ccount Payment of Amount from the Trust Account to Holders Payment of amount from the trust account to holders. Description Of Organization And Business Operations [Line Items] Number of stock units granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Number of Shares, Granted Property, Plant and Equipment, Estimated Useful Lives Estimated useful life exercise price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Granted Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Unvested Restricted Stock Rights Noncash Investing and Financing Items [Abstract] Supplemental disclosure of non-cash investing activities: